Fisher & Paykel Healthcare | FPH - Sales Revenues

Stock Price
32.70
Daily Change
-1.17 -3.45%
Monthly
-1.30%
Yearly
4.27%
Q1 Forecast
33.01

Fisher & Paykel Healthcare reported NZD1.09B in Sales Revenues for its fiscal semester ending in September of 2025.





Sales Change Date
Cochlear AUD 585.65M 586.15M Jun/2025
CSL USD 3.54B 4.68B Jun/2025
Nanosonics AUD 105.03M 11.44M Jun/2025
Ramsay Health Care AUD 9.29B 32.2M Dec/2025
ResMed USD 1.42B 87.23M Dec/2025
Sonic Healthcare AUD 4.98B 311M Jun/2025